Please wait while we open this resource.
K
Guidelines & protocols
PHARMACOLOGIC TREATMENT OF PRIMARY OSTEOPOROSIS OR LOW BONE MASS TO PREVENT FRACTURES IN ADULTS: A LIVING CLINICAL GUIDELINE FROM THE AMERICAN COLLEGE OF PHYSICIANS
American College of Physicians
PDF202318 pages529 KB
The document presents updated recommendations based on a systematic review of evidence regarding the pharmacologic treatment of primary osteoporosis or low bone mass. It includes strong and conditional recommendations for the use of bisphosphonates and other treatments for specific patient populations, particularly postmenopausal females. The guideline aims to assist clinicians in making informed treatment decisions to reduce fracture risk in adults with osteoporosis.
No account needed
Ask this resource
Answers use this document only.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Uganda Diabetes Management Guidelines – Summarised (2026)
Same clinical topic · Endocrinology
Kiruddu DKA guidelines
Same clinical topic · Endocrinology
Pharmacotherapy for Obesity Management: 2025 Guidelines
Same clinical topic · Endocrinology
Management of DKA
Same clinical topic · Endocrinology
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY CONSENSUS STATEMENT ALGORITHM FOR MANAGEMENT OF ADULTS WITH TYPE 2 DIABETES — 2026 UPDATE
Same clinical topic · Endocrinology
GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CONGENITAL HYPOTHYROIDISM
Same clinical topic · Endocrinology
2026 ETA GUIDELINE ON INTERFERENCE IN IMMUNOASSAY MEASUREMENTS USED IN ASSESSMENT OF THYROID FUNCTION
Same clinical topic · Endocrinology
CANADIAN ADULT OBESITY CLINICAL PRACTICE GUIDELINE: PHARMACOTHERAPY FOR OBESITY MANAGEMENT IN ADULTS
Same clinical topic · Endocrinology
Nutritional Management of Diabetes SOP (2)
Same clinical topic · Endocrinology